Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinoma, Neuroendocrine
×
30 days
×
Clear all
Filters
3
NCT07129252
2026-03-10
BRAVESST2
Crinetics Pharmaceuticals Inc.
Phase 1/2
Recruiting
150 enrolled